Search Within

Carol Portlock

Formats
  1. Journal Article (104)
  2. Meeting Abstract (90)
  3. Book Section (10)
  4. Conference Paper (1)
  5. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (206)
  2. Department of Medicine (206)
  3. Hematologic Malignancies, Division of (206)
  4. Lymphoma (206)
  5. Survivorship Research (97)
  6. Population Sciences Research Program (66)

More Groups

People
  1. Andrew Zelenetz (116)
  2. Craig Moskowitz (106)
  3. David Straus (102)
  4. Ariela Noy (93)
  5. Paul Hamlin (82)
  6. Steven Horwitz (62)

More People

Years
  1. 2024 (3)
  2. 2021 (3)
  3. 2020 (1)
  4. 2019 (6)
  5. 2018 (2)
  6. 2017 (12)

More Years

Publications
  1. Blood (65)
  2. Journal of Clinical Oncology (22)
  3. Annals of Oncology (16)
  4. Cancer (8)
  5. British Journal of Haematology (7)
  6. Leukemia and Lymphoma (7)

More Publications

Publishers
  1. American Society of Hematology (68)
  2. American Society of Clinical Oncology (22)
  3. Oxford University Press (16)
  4. Wiley Blackwell (14)
  5. Elsevier Inc. (12)
  6. Lippincott Williams & Wilkins (11)

More Publishers

Results (206)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term cardiac and pulmonary complications of cancer therapy
    Journal Article

    Yahalom, J.; Portlock, C. S.
    Hematology/Oncology Clinics of North America (2008)

    Fulltext@MSK | Save
  • Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): Developing a lymphoma prevention strategy
    Journal Article

    Portlock, C. S.; Hamlin, P.; Noy, A.; Chey, W.; Gaydos, C. A.; Palomba, L.; Schwartz, I.; Corcoran, S.; Rosenzweig, L.; Walker, D.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma
    Journal Article

    O'Connor, O. A.; Portlock, C.; Moskowitz, C.; Straus, D.; Hamlin, P.; Stubblefield, M.; Dumitrescu, O.; Colevas, A. D.; Grant, B.; Zelenetz, A.
    British Journal of Haematology (2008)

    Fulltext@MSK | Save
  • Patients with Epstein Barr virus-positive lymphomas have decreased CD4 + T-cell responses to the viral nuclear antigen 1
    Journal Article

    Heller, K. N.; Arrey, F.; Steinherz, P.; Portlock, C.; Chadburn, A.; Kelly, K.; Münz, C.
    International Journal of Cancer (2008)

    Fulltext@MSK | Save
  • EBV-positive lymphoma patients have a selective deficiency in EBV immunity
    Meeting Abstract

    Heller, K. N.; Steinherz, P. G.; Portlock, C. S.; Münz, C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Predictors of initial treatment in older adults with follicular non-Hodgkin lymphoma
    Meeting Abstract

    Elkin, E. B.; Portlock, C.; Yahalom, J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The management of Hodgkin lymphoma during pregnancy
    Book Section

    Portlock, C. S.; Yahalom, J.
    In Hoppe, R. T.; Mauch, P. M.; Armitage, J. O.; Diehl, V.; Weiss, L. M. (Eds.) Hodgkin Lymphoma. 2nd ed (2007)

    Fulltext@MSK | Save
  • A phase '2-1-2' study of two different doses and schedules of pralatrexate, a high affinity substrate for the reduced folate carrier (RFC-1), in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P.; Portlock, C.; Moskowitz, C.; Noy, A.; Straus, D.; Dumetrescu, O.; Sarasohn, D.; Neylon, E.; Hamelers, R.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Pattern of single agent Rituximab usage in indolent lymphoma and CLL beyond GELF and NCI criteria
    Meeting Abstract

    Cohler, C.; Brick Turin, Y.; Hamlin, P.; Portlock, C.; Zelenetz, A. D.; Noy, A.
    Blood (2007)

    Fulltext@MSK | Save
  • Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma
    Journal Article

    O'Connor, O. A.; Hamlin, P. A.; Portlock, C.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Macgregor-Cortelli, B.; Neylon, E.; Sarasohn, D.; Dumetrescu, O.; more...
    British Journal of Haematology (2007)

    Fulltext@MSK | Save